Heart failure (HF) symptoms and quality of life can be improved by use of the Sapien 3 aortic balloon-expandable transcatheter heart valve (THV) in patients undergoing transcatheter mitral valve-in-valve (MViV), valve-in-ring (MViR) and valve-in-mitral annular calcifications (ViMAC), particularly MViV, a new investigation shows.